Introduction: Our aim was to examine the value of indirect signs of open spina bifida in the mid-sagittal view of the posterior brain at the 11-13 weeks' ultrasound examination and to summarize the current evidence for the first-trimester diagnosis of spina bifida. Methods: This was a prospective study in routine obstetric population. The presence of four almost parallel lines (four-line view) in the posterior brain was recorded. Biparietal diameter (BPD), intracranial translucency (IT) and cisterna magna (CM) were measured. The ratio of IT to CM (R ratio) was calculated. Results: 2,491 pregnancies were examined prospectively. Updated reference ranges for IT and CM were constructed. There were 3 cases with open spina bifida, and the four-line view was abnormal in 2 of them. The abnormal fetuses had smaller BPD as well as pronounced reduction in the CM and increase in the R ratio. Discussion: Examination of the posterior brain was feasible in all fetuses in the setting of the routine 11-13 weeks' ultrasound examination. Indirect signs of spina bifida are visible in the mid-sagittal view of the posterior brain, and the assessment of these structures can be a reliable tool in the early identification of this abnormality.

Keywords:
Four-line view, 11ߝ13 weeksߣ scan, Spina bifida, Intracranial translucency, Cisterna magna
1.
Souka AP, Pilalis A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A: Assessment of fetal anatomy at the 11-14-week ultrasound examination. Ultrasound Obstet Gynecol 2004;24:730-734.
2.
Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH: Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011;31:90-102.
3.
Sebire NJ, Noble PL, Thorpe-Beeston JG, Snijders RJ, Nicolaides KH: Presence of the ‘lemon' sign in fetuses with spina bifida at the 10-14-week scan. Ultrasound Obstet Gynecol 1997;10:403-405.
4.
Pilalis A, Basagiannis C, Eleftheriades M, Faros E, Troukis E, Armelidou E, Papastefanou I, Souka AP: Evaluation of a two-step ultrasound examination protocol for the detection of major fetal structural defects. J Matern Fetal Neonatal Med 2012;25:1814-1817.
5.
Nicolaides KH, Campbell S, Gabbe SG, Guidetti R: Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986;2:72-74.
6.
Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, Prefumo F, Toi A, Lee W; ISUOG Clinical Standards Committee: Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2011;37:116-126.
7.
McLone DG, Dias MS: The Chiari II malformation: cause and impact. Childs Nerv Syst 2003;19:540-550.
8.
Buisson O, De Keersmaecker B, Senat MV, Bernard JP, Moscoso G, Ville Y: Sonographic diagnosis of spina bifida at 12 weeks: heading towards indirect signs. Ultrasound Obstet Gynecol 2002;19:290-292.
9.
Blaas HG, Eik-Nes SH, Isaksen CV: The detection of spina bifida before 10 gestational weeks using two- and three-dimensional ultrasound. Ultrasound Obstet Gynecol 2000;16:25-29.
10.
Blumenfeld Z, Siegler E, Bronshtein M: The early diagnosis of neural tube defects. Prenat Diagn 1993;13:863-871.
11.
Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicolaides KH: Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan: Ultrasound Obstet Gynecol 2009;34:249-252.
12.
Chaoui R, Benoit B, Heling KS, Kagan KO, Pietzsch V, Sarut Lopez A, Tekesin I, Karl K: Prospective detection of open spina bifida at 11-13 weeks by assessing intracranial translucency and posterior brain. Ultrasound Obstet Gynecol 2011;38:722-726.
13.
Egle D, Strobl I, Weiskopf-Schwendinger V, Grubinger E, Kraxner F, Mutz-Dehbalaie IS, Strasak A, Scheier M: Appearance of the fetal posterior fossa at 11+3 to 13+6 gestational weeks on transabdominal ultrasound examination. Ultrasound Obstet Gynecol 2011;38:620-624.
14.
Lachmann R, Chaoui R, Moratalla J, Picciarelli G, Nicolaides KH: Posterior brain in fetuses with open spina bifida at 11 to 13 weeks. Prenat Diagn 2011;31:103-106.
15.
Kavalakis I, Souka AP, Pilalis A, Papastefanou I, Kassanos D: Assessment of the posterior brain at 11-14 weeks for the prediction of open neural tube defects. Prenat Diagn 2012;32:1143-1146.
16.
Garcia-Posada R, Eixarch E, Sanz M, Puerto B, Figueras F, Borrell A: Cisterna magna width at 11-13 weeks in the detection of posterior fossa anomalies. Ultrasound Obstet Gynecol 2013;41:515-520.
17.
Souka AP, Pilalis A, Papastefanou I, Salamalekis G, Kassanos D: Reproducibility study of crown-rump length and biparietal diameter measurements in the first trimester. Prenat Diagn 2012;32:1158-1165.
18.
Royston P, Wright EM: How to construct ‘normal ranges' for fetal variables. Ultrasound Obstet Gynecol 1998;11:30-38.
19.
Lachmann R, Picciarelli G, Moratalla J, Greene N, Nicolaides KH: Frontomaxillary facial angle in fetuses with spina bifida at 11-13 weeks' gestation. Ultrasound Obstet Gynecol 2010;36:268-271.
20.
Finn M, Sutton D, Atkinson S, Ransome K, Sujenthiran P, Ditcham V, Wakefield P, Meagher S: The aqueduct of Sylvius: a sonographic landmark for neural tube defects in the first trimester. Ultrasound Obstet Gynecol 2011;38:640-645.
21.
Khalil A, Coates A, Papageorghiou A, Bhide A, Thilaganathan B: Biparietal diameter at 11-13 weeks' gestation in fetuses with open spina bifida. Ultrasound Obstet Gynecol 2013;42:409-415.
22.
Karl K, Benoit B, Entezami M, Heling KS, Chaoui R: Small biparietal diameter in fetuses with spina bifida on 11-13-week and mid-gestation ultrasound. Ultrasound Obstet Gynecol 2012;40:140-144.
23.
Bernard JP, Cuckle HS, Stirnemann JJ, Salomon LJ, Ville Y: Screening for fetal spina bifida by ultrasound examination in the first trimester of pregnancy using fetal biparietal diameter. Am J Obstet Gynecol 2012;207:306.e1-e5.
24.
Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH: First-trimester screening for neural tube defects using alpha-fetoprotein. Fetal Diagn Ther 2012;31:109-114.
25.
Scheier M, Lachmann R, Pětroš M, Nicolaides KH: Three-dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11-13 weeks' gestation. Ultrasound Obstet Gynecol 2011;38:625-629.
26.
Loureiro T, Ushakov F, Montenegro N, Gielchinsky Y, Nicolaides KH: Cerebral ventricular system in fetuses with open spina bifida at 11-13 weeks' gestation. Ultrasound Obstet Gynecol 2012;39:620-624.
27.
Papastefanou I, Souka AP, Pilalis A, Panagopoulos P, Kassanos D: Fetal intracranial translucency and cisterna magna at 11 to 14 weeks: reference ranges and correlation with chromosomal abnormalities. Prenat Diagn 2011;31:1189-1192.
28.
Adzick NS, Thom EA, Spong CY, Brock JW 3rd, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D'Alton ME, Farmer DL; MOMS Investigators: A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364:993-1004.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.